188 related articles for article (PubMed ID: 23768781)
1. The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.
Liu X; Ye M; An C; Pan L; Ji L
Biomaterials; 2013 Sep; 34(28):6893-905. PubMed ID: 23768781
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia.
Liu X; An C; Jin P; Liu X; Wang L
Biomaterials; 2013 Jan; 34(3):817-30. PubMed ID: 23111336
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
4. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
Lu W; Wan J; She Z; Jiang X
J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
[TBL] [Abstract][Full Text] [Related]
5. Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles.
Xu F; Lu W; Wu H; Fan L; Gao X; Jiang X
J Drug Target; 2009 Jul; 17(6):423-34. PubMed ID: 19527113
[TBL] [Abstract][Full Text] [Related]
6. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
Xie YL; Lu W; Jiang XG
Behav Brain Res; 2006 Oct; 173(1):76-84. PubMed ID: 16828890
[TBL] [Abstract][Full Text] [Related]
8. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK
J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844
[TBL] [Abstract][Full Text] [Related]
9. Anti-nociceptive effects of Tanshinone IIA (TIIA) in a rat model of complete Freund's adjuvant (CFA)-induced inflammatory pain.
Sun S; Yin Y; Yin X; Cao F; Luo D; Zhang T; Li Y; Ni L
Brain Res Bull; 2012 Sep; 88(6):581-8. PubMed ID: 22705002
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of polyethylene glycol-conjugated urokinase nanogels in rat models of ischemic stroke when administrated outside the usual time window.
Cui W; Liu R; Jin H; Huang Y; Liu W; He M
Biochem Biophys Res Commun; 2020 Mar; 523(4):887-893. PubMed ID: 31955887
[TBL] [Abstract][Full Text] [Related]
11. Brain-targeting delivery for RNAi neuroprotection against cerebral ischemia reperfusion injury.
An S; Kuang Y; Shen T; Li J; Ma H; Guo Y; He X; Jiang C
Biomaterials; 2013 Nov; 34(35):8949-59. PubMed ID: 23968852
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA suppresses lung injury and apoptosis, and modulates protein kinase B and extracellular signal-regulated protein kinase pathways in rats challenged with seawater exposure.
Li JH; Xu M; Xie XY; Fan QX; Mu DG; Zhang Y; Cao FL; Wang YX; Zhao PT; Zhang B; Jin FG; Li ZC
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):269-77. PubMed ID: 21314841
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway.
Maione F; De Feo V; Caiazzo E; De Martino L; Cicala C; Mascolo N
J Ethnopharmacol; 2014 Sep; 155(2):1236-42. PubMed ID: 25038434
[TBL] [Abstract][Full Text] [Related]
14. Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes.
Pang Z; Gao H; Chen J; Shen S; Zhang B; Ren J; Guo L; Qian Y; Jiang X; Mei H
Int J Nanomedicine; 2012; 7():3421-32. PubMed ID: 22848168
[TBL] [Abstract][Full Text] [Related]
15. Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats.
Liu Z; Zhang L; He Q; Liu X; Okeke CI; Tong L; Guo L; Yang H; Zhang Q; Zhao H; Gu X
Int J Pharm; 2015 Jul; 489(1-2):131-8. PubMed ID: 25895718
[TBL] [Abstract][Full Text] [Related]
16. [Study on regulation of tanshinone II(A) on GFAP and ATPase and PDI of cerebral ischemia reperfusion injury in rats].
Wen PY; Yang FZ; Wang F; Li WW; Zhou L; Huang LH; Zhou J
Zhong Yao Cai; 2012 Oct; 35(10):1628-32. PubMed ID: 23627131
[TBL] [Abstract][Full Text] [Related]
17. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of tanshinone IIA and/or tetramethylpyrazine in cerebral ischemic injury in vivo and in vitro.
Tang Q; Han R; Xiao H; Shen J; Luo Q; Li J
Brain Res; 2012 Dec; 1488():81-91. PubMed ID: 23063715
[TBL] [Abstract][Full Text] [Related]
19. Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles.
Lim SM; Kim TH; Jiang HH; Park CW; Lee S; Chen X; Lee KC
Biomaterials; 2011 May; 32(13):3538-46. PubMed ID: 21306770
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
